TY - JOUR
T1 - CARACTERÍSTICAS CLÍNICAS Y EPIDEMIOLÓGICAS DE EQUINOCOCOSIS QUÍSTICA EN NIÑOS DE UN CENTRO TERCIARIO EN PERÚ
AU - Salazar-Mesones, Blanca
AU - Luna-Vílchez, Medalit
AU - Maquera-Afaray, Julio
AU - Chiara-Chilet, Christian
AU - Portillo-álvarez, Diana
AU - López Revilla, José Wagner
N1 - Publisher Copyright:
© 2022, Instituto Nacional de Salud. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Cystic echinococcosis (CE) in children is a public health problem. To describe the clinical and epidemio-logical profile of CE, we reviewed the records of 55 children admitted to our institution with a confirmed diagnosis of CE between 2017-2019, analyzing demographic data, clinical manifestations, and treatment. Male sex was 61,8% (34/55), median age was 9,25+2,79 years; 16,4% had previous CE diagnosis, and 50,9% had contact with dogs. The median time of illness was 2 months. 65,5% had hepatic involvement, 56,4% had pulmonary involvement, and 21,8% had both hepatic and pulmonary involvement. The most frequent symptoms were abdominal pain (80,6%) and cough (80,6%). Surgical treatment was performed in 87,5% of hepatic CE and 100% of pulmonary CE and hepatic and pulmonary CE. Albendazole was prescribed in 100% of hepatic cases, in 73,7% of pulmonary cases, and 75% of both affections. No mortality was reported.
AB - Cystic echinococcosis (CE) in children is a public health problem. To describe the clinical and epidemio-logical profile of CE, we reviewed the records of 55 children admitted to our institution with a confirmed diagnosis of CE between 2017-2019, analyzing demographic data, clinical manifestations, and treatment. Male sex was 61,8% (34/55), median age was 9,25+2,79 years; 16,4% had previous CE diagnosis, and 50,9% had contact with dogs. The median time of illness was 2 months. 65,5% had hepatic involvement, 56,4% had pulmonary involvement, and 21,8% had both hepatic and pulmonary involvement. The most frequent symptoms were abdominal pain (80,6%) and cough (80,6%). Surgical treatment was performed in 87,5% of hepatic CE and 100% of pulmonary CE and hepatic and pulmonary CE. Albendazole was prescribed in 100% of hepatic cases, in 73,7% of pulmonary cases, and 75% of both affections. No mortality was reported.
KW - Echinococcosis
KW - Echinococcosis; Echinococcus granulosus
KW - Hepatic; Echinococcosis
KW - Pulmo-nary; Children (source: MeSH NLM)
UR - http://www.scopus.com/inward/record.url?scp=85128432422&partnerID=8YFLogxK
U2 - 10.17843/rpmesp.2022.391.9830
DO - 10.17843/rpmesp.2022.391.9830
M3 - Artículo
AN - SCOPUS:85128432422
SN - 1726-4634
VL - 39
SP - 65
EP - 69
JO - Revista Peruana de Medicina Experimental y Salud Publica
JF - Revista Peruana de Medicina Experimental y Salud Publica
IS - 1
ER -